
|Videos|February 18, 2021
Dr. Alexander Kutikov on the COVID-19 vaccine and patients with GU cancers
Author(s)Urology Times staff
“The biggest risk that our patients face is a severe COVID-19 episode,” says Kutikov.
Advertisement
Alexander Kutikov, MD, discusses his experience with the COVID-19 vaccine and patients with genitourinary cancer. Kutikov is chief, Division of Urology and Urologic Oncology, professor, Department of Surgical Oncology, and Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
High PHI scores are linked to increased odds of significant prostate cancer
3
Estradiol and ADT: Lessons from Lived Experience
4
Estradiol Patches in Prostate Cancer: Evidence and Impact
5




















